Medical Aspects of Chemical Warfare (2008) - The Black Vault

Medical Aspects of Chemical Warfare (2008) - The Black Vault Medical Aspects of Chemical Warfare (2008) - The Black Vault

documents.blackvault.com
from documents.blackvault.com More from this publisher
13.07.2015 Views

Medical DiagnosticsClHAsCCClClHaH 2OOHHAsCCOHClHbEDTPDTBALSCH 2SCH 2HClCAsC SHLogan (1999) 1CH 2HClCAsC SHWooten (2002) 2CH 2CH 2SCH 2HAsCCSCHClHCH 2OHcHFBISCH 2HAsFiddler (2000) 3CCSCHClHCH 2OC(O)C 3F 7Fig. 22-12. Published analytical approaches for the analysis of chlorovinylarsonous acid in urine. (a) Reaction of lewisite(trans isomer shown) with water to form chlorovinylarsonous acid. (b) Reactions of chlorovinylarsonous acid with thiolcompounds ethanedithiol, propanedithiol, and British anti-Lewisite. 1,2,3 (c) Derivatization using HFBI. 3BAL: British anti-LewisiteEDT: ethanedithiolH 2O: dihydrogen monoxide; waterHFBI: heptafluorobutyryl imidazolePDT: propanedithiolData sources: (1) Logan TP, Smith JR, Jakubowski EM, Nielson RE. Verification of lewisite exposure by the analysis of 2-chlorovinyl arsonous acid in urine. Toxicol Meth. 1999;9:275–284. (2) Wooten JV, Ashley DL, Calafat AM. Quantitation of 2-chlorovinylarsonous acid in human urine by automated solid-phase microextraction-gas chromatography-mass spectrometry.J Chromatogr B Analyt Technol Biomed Life Sci. 2002;772:147–153. (3) Fidder A, Noort D, Hulst AG, de Jong LP, Benschop HP.Biomonitoring of exposure to lewisite based on adducts to haemoglobin. Arch Toxicol. 2000;74:207–214.729

Medical Aspects of Chemical WarfareEXHIBIT 22-4SAMPLE PREPARATION METHODS FOR Gas Chromatographic/MassSpectrometric ANALYSIS OF chlorovinylarsonous acidSPE procedure of Logan et al for CVAA in urine:• Precondition a C18 SPE cartridge with methanol followed by water.• Adjust pH of 1 mL of urine to pH 6 using HCl.• Add PAO as an internal standard.• Transfer sample to C18 SPE cartridge for sample cleanup/extraction.• Elute analytes using methanol.• Evaporate to dryness under nitrogen.• Reconstitute with ethanol containing EDT.• Analyze using GC-MS with EI ionization. 1SPME headspace procedure of Wooten et al for CVAA in urine:• Place 1 mL of urine into a 10-mL vial.• Add ammonium acetate buffer-water solution.• Add PAO as an internal standard.• Add PDT in order to derivatize CVAA and PAO.• Crimp-seal vial and heat at 70°C for 20 min.• Insert a 100-μM poly(dimethylsiloxane) SPME fiber into the sample vial headspace for 10 min.• Remove the SPME fiber from the vial and insert into the injection port of a GC-MS with EI ionization. 2SPE procedure of Fidder et al for free and bound CVAA in blood:• Add 2,3-dimercapto-1-propanol (BAL) to a 2-mL blood sample. The BAL causes displacement of bound CVAAand derivatizes both the free and released CVAA.• Add phenylarsine-BAL as an internal standard.• Shake the sample at room temperature overnight.• Dilute the sample with water.• Transfer sample to C18 SPE cartridge for sample cleanup/extraction.• Elute the analytes from the cartridge using dichloromethane/acetonitrile mixture.• Concentrate the extracted sample to dryness.• Redissolve in toluene.• Add HFBI to derivatize the BAL hydroxyl group.• Incubate the sample for 1 hour at 50°C and then cool to room temperature.• Wash with water and then dry over MgSO 4.• Analyze using GC-MS with EI ionization. 3BAL: British anti-LewisiteCVAA: chlorovinylarsonous acidEDT: ethanedithiolEI: electron impactGC: gas chromatographyHCl: hydrochloric acidHFBI: heptafluorobutyryl imidazoleMS: mass spectrometryPAO: phenylarsine oxidePDT: 1,3-propanedithiolSPE: solid phase extractionSPME: solid phase microextractionData sources: (1) Logan TP, Smith JR, Jakubowski EM, Nielson RE. Verification of lewisite exposure by the analysis of 2-chlorovinylarsonous acid in urine. Toxicol Meth. 1999;9:275–284. (2) Wooten JV, Ashley DL, Calafat AM. Quantitation of 2-chlorovinylarsonousacid in human urine by automated solid-phase microextraction-gas chromatography-mass spectrometry. J Chromatogr B Analyt TechnolBiomed Life Sci. 2002;772:147–153. (3) Fidder A, Noort D, Hulst AG, de Jong LP, Benschop HP. Biomonitoring of exposure to lewisitebased on adducts to haemoglobin. Arch Toxicol. 2000;74:207–214.730

<strong>Medical</strong> <strong>Aspects</strong> <strong>of</strong> <strong>Chemical</strong> <strong>Warfare</strong>EXHIBIT 22-4SAMPLE PREPARATION METHODS FOR Gas Chromatographic/MassSpectrometric ANALYSIS OF chlorovinylarsonous acidSPE procedure <strong>of</strong> Logan et al for CVAA in urine:• Precondition a C18 SPE cartridge with methanol followed by water.• Adjust pH <strong>of</strong> 1 mL <strong>of</strong> urine to pH 6 using HCl.• Add PAO as an internal standard.• Transfer sample to C18 SPE cartridge for sample cleanup/extraction.• Elute analytes using methanol.• Evaporate to dryness under nitrogen.• Reconstitute with ethanol containing EDT.• Analyze using GC-MS with EI ionization. 1SPME headspace procedure <strong>of</strong> Wooten et al for CVAA in urine:• Place 1 mL <strong>of</strong> urine into a 10-mL vial.• Add ammonium acetate buffer-water solution.• Add PAO as an internal standard.• Add PDT in order to derivatize CVAA and PAO.• Crimp-seal vial and heat at 70°C for 20 min.• Insert a 100-μM poly(dimethylsiloxane) SPME fiber into the sample vial headspace for 10 min.• Remove the SPME fiber from the vial and insert into the injection port <strong>of</strong> a GC-MS with EI ionization. 2SPE procedure <strong>of</strong> Fidder et al for free and bound CVAA in blood:• Add 2,3-dimercapto-1-propanol (BAL) to a 2-mL blood sample. <strong>The</strong> BAL causes displacement <strong>of</strong> bound CVAAand derivatizes both the free and released CVAA.• Add phenylarsine-BAL as an internal standard.• Shake the sample at room temperature overnight.• Dilute the sample with water.• Transfer sample to C18 SPE cartridge for sample cleanup/extraction.• Elute the analytes from the cartridge using dichloromethane/acetonitrile mixture.• Concentrate the extracted sample to dryness.• Redissolve in toluene.• Add HFBI to derivatize the BAL hydroxyl group.• Incubate the sample for 1 hour at 50°C and then cool to room temperature.• Wash with water and then dry over MgSO 4.• Analyze using GC-MS with EI ionization. 3BAL: British anti-LewisiteCVAA: chlorovinylarsonous acidEDT: ethanedithiolEI: electron impactGC: gas chromatographyHCl: hydrochloric acidHFBI: heptafluorobutyryl imidazoleMS: mass spectrometryPAO: phenylarsine oxidePDT: 1,3-propanedithiolSPE: solid phase extractionSPME: solid phase microextractionData sources: (1) Logan TP, Smith JR, Jakubowski EM, Nielson RE. Verification <strong>of</strong> lewisite exposure by the analysis <strong>of</strong> 2-chlorovinylarsonous acid in urine. Toxicol Meth. 1999;9:275–284. (2) Wooten JV, Ashley DL, Calafat AM. Quantitation <strong>of</strong> 2-chlorovinylarsonousacid in human urine by automated solid-phase microextraction-gas chromatography-mass spectrometry. J Chromatogr B Analyt TechnolBiomed Life Sci. 2002;772:147–153. (3) Fidder A, Noort D, Hulst AG, de Jong LP, Benschop HP. Biomonitoring <strong>of</strong> exposure to lewisitebased on adducts to haemoglobin. Arch Toxicol. 2000;74:207–214.730

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!